A Case of Steroid Resistant Minimal Change Disease Associated with Portal Vein Thrombosis Treated by Combined Immunosuppressive Agents
Author(s) -
Hyo Jin Jung,
Su Mi Lee,
Seo Hee Rha,
Seong Eun Kim,
Young Ki Son,
Ki Seung Kim,
Won Suk An
Publication year - 2017
Publication title -
kosin medical journal
Language(s) - English
Resource type - Journals
eISSN - 2586-7024
pISSN - 2005-9531
DOI - 10.7180/kmj.2017.32.1.90
Subject(s) - medicine , minimal change disease , nephrotic syndrome , thrombosis , portal vein thrombosis , renal vein thrombosis , gastroenterology , deep vein , surgery , glomerulonephritis , kidney , focal segmental glomerulosclerosis
Minimal change disease (MCD) is a common cause of nephrotic syndrome and relatively well responds with steroid treatment. However, nearly half of patients with MCD experience recurrence of nephrotic syndrome. Thromboembolic events including renal vein thrombosis may occur in patients with MCD, but portal vein thrombosis rarely occurs. We experienced a case of frequent relapse/steroid dependent MCD with nephrotic syndrome progressed to steroid resistance associated with portal vein thrombosis. This patient showed complete remission of MCD and resolution of portal vein thrombosis after treatment with corticosteroid, cyclosporine, mycophenolate mofetil, and anticoagulant.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom